Neuroleptic malignant syndrome due to atypical neuroleptics: Three episodes in one patient

Pharmacopsychiatry

Volumn 35, Issue 3, 2002, Pages 119-121

  Bottlender, Roland ^a   Jager M ^a   Hofschuster, E ^a   Dobmeier, P ^a   Moller H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; AMITRIPTYLINE; CLOZAPINE; MELPERONE; NEUROLEPTIC AGENT; PROTHIPENDYL; RISPERIDONE; TRIMIPRAMINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; NEUROLEPTIC MALIGNANT SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; RISPERIDONE; SCHIZOPHRENIA; SULPIRIDE;

EID: 0036084257     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-31518     Document Type: Article

References (29)

1. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients
2. Neuroleptic malignant syndrome associated with clozapine use
3. Risperidone-induced neuroleptic malignant syndrome
4. Catatonia and the neuroleptics: Psychobiologic significance of remote and recent findings
5. Neuroleptic malignant syndrome, amitriptyline and thioridazine
6. Clozapine-induced neuroleptic malignant syndrome
7. High-dose trimipramine in acute schizophrenia. Preliminary results of an open trial
8. Toxic serotonin syndrome or neuroleptic malignant syndrome
9. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome
10. The serotonin syndrome scale: First results on validity
11. CYP2D6 genotype and possible susceptibility to the neuroleptic malignant syndrome
12. Clozapine-associated neuroleptic malignant syndrome: Two new cases and a review of the literature
13. Mutation involving cytochrome P45011D6 in two Japanese patients with neuroleptic malignant syndrome
14. Delayed risperidone-induced neuroleptic malignant syndrome
15. A case of delayed NMS induced by risperidone
16. Withdrawal NMS after drug treatment
17. A case of clozapine-induced neuroleptic malignant syndrome
18. Encephalopathy during amitriptyline therapy: Are neuroleptic malignant syndrome and serotonin syndrome spectrum disorders?
19. Atypical neuroleptic malignant syndrome associated with risperidon treatment
20. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital
21. Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome
22. Myotoxicity and neurotoxicity during clozapine treatment
23. The neuroleptic malignant syndrome. Agent and host interaction
24. Risperidone-induced neuroleptic malignant syndrome
25. Two cases of risperidone-induced neuroleptic malignant syndrome
26. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment
27. Clozapine withdrawal resulting in delirium with psychosis: A report of three cases
28. The serotonin syndrome